Facebook Instagram Linkedin Youtube
Home Tags Immuno-oncology

Tag: Immuno-oncology

Alligator’s mitazalimab data published in The Lancet Oncology

Alligator’s mitazalimab data published in The Lancet Oncology

Alligator to maximise immuno-oncology innovation

Alligator to maximise immuno-oncology innovation

Alligator CD40 durable

Phase II results indicate durability of response for Alligator’s CD40 agonist

Elicera uppdaterar i samband med Cancer Immunotherapy Month

Elicera gives an update in Cancer Immunotherapy Month

Alligator milestones mitazalimab

Alligator gearing up for new milestones with mitazalimab

Alligator CEO rights issue (1)

Alligator’s CEO on current development and the rights issue

Ultimovacs INITIUM study timeline

Ultimovacs updates INITIUM study timeline

Alligator_CMOwebinar

Alligator’s CMO hosts in-depth webinar on Mitazalimab

Ultimovacs on track for phase II

Ultimovacs on track to phase II readout

Elicera Q4 2022

Advancements for Elicera in 2022 open for intensive clinical year

12Page 1 of 2
© BioStock 2024